Why GLP-1s Cause Muscle Loss — And How to Stop It

Why GLP-1s Cause Muscle Loss — And How to Stop It

Heald Membership: Your Path to Diabetes Reversal

sandeep msira

Sandeep Misra

Sandeep Misra

Posted on

Posted on

by

by

Medically Reviewed By:

Medically Reviewed By:

Dr. Sumeet Arora

Dr. Sumeet Arora

Table of content

Title

The scale is moving. So why do you feel weaker?

If you're on a GLP-1 medication like semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro or Zepbound) and you've noticed you're losing weight but feeling weaker, more tired, or looking 'softer' despite the numbers going down — you're not imagining it. There's a clinical reason for it, and it's one of the most under-discussed side effects of these medications.

What the research actually shows

A systematic review published in PubMed examined 1,541 patients across six semaglutide studies and found that lean mass reductions ranging from near zero to 40% of total weight lost were observed depending on the individual. A 2025 report from the American Diabetes Association confirmed the same figure: as much as 40% of weight lost on GLP-1s can come from lean muscle rather than fat.

That number matters more than it sounds. Muscle isn't just about how you look or how strong you are. It's the primary driver of your resting metabolic rate — the number of calories your body burns just to stay alive. When you lose muscle, your metabolism slows. And a slower metabolism creates a dangerous setup for what happens next.

The weight regain trap

The STEP 1 trial extension — one of the largest studies on semaglutide outcomes — found that participants regained two-thirds of their prior weight loss within one year of stopping the medication. A 2025 meta-analysis in eClinicalMedicine found that people stopping semaglutide or tirzepatide regained an average of nearly 10 kg within the first year after stopping.

Here's what most people aren't told: a significant part of that regain risk comes from the muscle loss that happened during treatment. When your metabolic engine is smaller, your body simply can't sustain the weight loss without the drug doing the work. The medication was compensating for the muscle you lost.

Why this happens on GLP-1s specifically

GLP-1 medications suppress appetite so effectively that most people dramatically reduce their caloric intake — often below what the body needs to maintain muscle tissue. When protein intake drops and resistance training isn't in place, the body turns to muscle as a fuel source. It's not the medication itself destroying muscle. It's the nutritional gap the medication creates.


Diabetes Prevention Program (DPP)

Diabetes Prevention Program (DPP)

Designed By

Designed By

Let's Reverse Type-2 Diabetes

Let's Reverse
Type-2 Diabetes

Prevent Type 2 Diabetes with a CDC-Recognised Program — Available at Zero Cost Based on Eligibility.

Prevent Type 2 Diabetes with a CDC-Recognised Program — Available at Zero Cost Based on Eligibility.

What actually prevents muscle loss on GLP-1s

Research and clinical experience point to three things that work together:

1. Protein intake — aim for at least 1.2–1.6g per kg of body weight daily. When appetite is suppressed, this requires deliberate structuring of meals, not just 'eating more protein'.

2. Resistance training — even two sessions per week of bodyweight or light dumbbell work sends a preservation signal to your muscles. A 2024 case series in PMC showed patients who incorporated resistance training lost as little as 6.9% lean mass versus the typical 25–40%.

3. Controlled rate of weight loss — losing weight too fast accelerates muscle loss. Slower, supported weight loss preserves more lean tissue.

Frequently asked questions:

  1. How do I know if I'm losing muscle vs. fat?

    Common signs include feeling weaker despite weight loss, looking 'softer' even as the scale drops, increased fatigue, and reduced performance in everyday activities like climbing stairs. A DEXA scan can confirm body composition changes.

  2. Does this happen with all GLP-1 medications?

    Yes — the mechanism is consistent across semaglutide, tirzepatide, and liraglutide. The degree varies depending on dose, duration, diet, and activity level.

Take the free Heald quiz:

Not sure how your body is responding to your GLP-1 medication? Our 2-minute quiz identifies your specific side effect pattern and tells you exactly what your body needs.

Take the Quiz. Get Your Guide.

Sources:  (1) PubMed 38629387 — Systematic review: semaglutide & lean mass. (2) ADA 2025 — BELIEVE trial & muscle preservation. (3) PMC STEP 1 extension — weight regain after stopping semaglutide. (4) eClinicalMedicine 2025 — metabolic rebound meta-analysis.


About the Author

About the Author

Sandeep Misra is the Co-Founder and Chief Growth Officer at Heald, where he leads growth strategy and partnerships for data-driven programs focused on diabetes reversal and metabolic health. He brings over two decades of experience across healthcare technology, population health, and enterprise partnerships, having held senior leadership roles at AWS, Rackspace, and NTT Data.


Connect on LinkedIn

Popular Blogs

Comments

HealD Logo

Get Connected with us on:

Address:

Completum health Inc,
Tech Alpharetta
925 North Point Parkway,
Suite 130,
Alpharetta, GA 30005

© Copyright Heald. All Rights Reserved

HealD Logo

Get Connected with us on:

Address:

Completum health Inc,
Tech Alpharetta
925 North Point Parkway,
Suite 130,
Alpharetta, GA 30005

© Copyright Heald. All Rights Reserved

HealD Logo

Get Connected with us on:

Address:

Completum health Inc,
Tech Alpharetta
925 North Point Parkway, Suite 130, Alpharetta, GA 30005

© Copyright Heald. All Rights Reserved

Got any questions? I'm happy to help.